{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:11:39Z","timestamp":1790071899409,"version":"4.0.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81471935"],"award-info":[{"award-number":["No. 81471935"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Natural Science Foundation of China (NSFC-NIH project)","award":["No. 81561128007"],"award-info":[{"award-number":["No. 81561128007"]}]},{"name":"Important Key Program of Natural Science Foundation of China","award":["No. 81590765"],"award-info":[{"award-number":["No. 81590765"]}]},{"DOI":"10.13039\/100012540","name":"Introduction of Innovative R&D Team Program of Guangdong Province","doi-asserted-by":"crossref","award":["No. 2009010058"],"award-info":[{"award-number":["No. 2009010058"]}],"id":[{"id":"10.13039\/100012540","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Joint-innovation Program in Healthcare for Special Scientific Research Projects of Guangzhou, China","award":["No. 201508020256"],"award-info":[{"award-number":["No. 201508020256"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12977-017-0382-1","type":"journal-article","created":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T08:18:54Z","timestamp":1513671534000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Moloney leukemia virus 10 (MOV10) inhibits the degradation of APOBEC3G through interference with the Vif-mediated ubiquitin\u2013proteasome pathway"],"prefix":"10.1186","volume":"14","author":[{"given":"Cancan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaocao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junsong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3863-7210","authenticated-orcid":false,"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,19]]},"reference":[{"key":"382_CR1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature01707","volume":"424","author":"H Zhang","year":"2003","unstructured":"Zhang H, Yang B, Pomerantz RJ, Zhang C, Arunachalam SC, Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature. 2003;424:94\u20138.","journal-title":"Nature"},{"key":"382_CR2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0092-8674(03)00515-4","volume":"114","author":"R Mariani","year":"2003","unstructured":"Mariani R, Chen D, Schrofelbauer B, Navarro F, Konig R, Bollman B, Munk C, Nymark-McMahon H, Landau NR. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell. 2003;114:21\u201331.","journal-title":"Cell"},{"key":"382_CR3","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1126\/science.1083338","volume":"300","author":"D Lecossier","year":"2003","unstructured":"Lecossier D, Bouchonnet F, Clavel F, Hance AJ. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science. 2003;300:1112.","journal-title":"Science"},{"key":"382_CR4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature01709","volume":"424","author":"B Mangeat","year":"2003","unstructured":"Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature. 2003;424:99\u2013103.","journal-title":"Nature"},{"key":"382_CR5","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1371\/journal.ppat.0030153","volume":"3","author":"K Bourara","year":"2007","unstructured":"Bourara K, Liegler TJ, Grant RM. Target cell APOBEC3C can induce limited G-to-A mutation in HIV-1. PLoS Pathog. 2007;3:1477\u201385.","journal-title":"PLoS Pathog"},{"key":"382_CR6","doi-asserted-by":"crossref","first-page":"7792","DOI":"10.1074\/jbc.M313093200","volume":"279","author":"A Mehle","year":"2004","unstructured":"Mehle A, Strack B, Ancuta P, Zhang C, McPike M, Gabuzda D. Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway. J Biol Chem. 2004;279:7792\u20138.","journal-title":"J Biol Chem"},{"key":"382_CR7","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/nm945","volume":"9","author":"AM Sheehy","year":"2003","unstructured":"Sheehy AM, Gaddis NC, Malim MH. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med. 2003;9:1404\u20137.","journal-title":"Nat Med"},{"key":"382_CR8","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.cub.2003.10.034","volume":"13","author":"SG Conticello","year":"2003","unstructured":"Conticello SG, Harris RS, Neuberger MS. The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr Biol. 2003;13:2009\u201313.","journal-title":"Curr Biol"},{"key":"382_CR9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1097-2765(03)00353-8","volume":"12","author":"K Stopak","year":"2003","unstructured":"Stopak K, de Noronha C, Yonemoto W, Greene WC. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol Cell. 2003;12:591\u2013601.","journal-title":"Mol Cell"},{"key":"382_CR10","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/nm946","volume":"9","author":"M Marin","year":"2003","unstructured":"Marin M, Rose KM, Kozak SL, Kabat D. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med. 2003;9:1398\u2013403.","journal-title":"Nat Med"},{"key":"382_CR11","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1126\/science.1089591","volume":"302","author":"X Yu","year":"2003","unstructured":"Yu X, Yu Y, Liu B, Luo K, Kong W, Mao P, Yu XF. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science. 2003;302:1056\u201360.","journal-title":"Science"},{"key":"382_CR12","doi-asserted-by":"crossref","first-page":"18573","DOI":"10.1074\/jbc.C500082200","volume":"280","author":"M Kobayashi","year":"2005","unstructured":"Kobayashi M, Takaori-Kondo A, Miyauchi Y, Iwai K, Uchiyama T. Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential for Vif function. J Biol Chem. 2005;280:18573\u20138.","journal-title":"J Biol Chem"},{"key":"382_CR13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature10693","volume":"481","author":"S Jager","year":"2012","unstructured":"Jager S, Kim DY, Hultquist JF, Shindo K, LaRue RS, Kwon E, Li M, Anderson BD, Yen L, Stanley D, et al. Vif hijacks CBF-beta to degrade APOBEC3G and promote HIV-1 infection. Nature. 2012;481:371\u20135.","journal-title":"Nature"},{"key":"382_CR14","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1101\/gad.1250204","volume":"18","author":"Y Yu","year":"2004","unstructured":"Yu Y, Xiao Z, Ehrlich ES, Yu X, Yu XF. Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines. Genes Dev. 2004;18:2867\u201372.","journal-title":"Genes Dev"},{"key":"382_CR15","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature10718","volume":"481","author":"W Zhang","year":"2012","unstructured":"Zhang W, Du J, Evans SL, Yu Y, Yu XF. T-cell differentiation factor CBF-beta regulates HIV-1 Vif-mediated evasion of host restriction. Nature. 2012;481:376\u20139.","journal-title":"Nature"},{"key":"382_CR16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1742-4690-10-94","volume":"10","author":"X Wang","year":"2013","unstructured":"Wang X, Wang X, Zhang H, Lv M, Zuo T, Wu H, Wang J, Liu D, Wang C, Zhang J, et al. Interactions between HIV-1 Vif and human ElonginB-ElonginC are important for CBF-beta binding to Vif. Retrovirology. 2013;10:94.","journal-title":"Retrovirology"},{"key":"382_CR17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0968-0004(92)90338-A","volume":"17","author":"EV Koonin","year":"1992","unstructured":"Koonin EV. A new group of putative RNA helicases. Trends Biochem Sci. 1992;17:495\u20137.","journal-title":"Trends Biochem Sci"},{"key":"382_CR18","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.molcel.2014.03.017","volume":"54","author":"LH Gregersen","year":"2014","unstructured":"Gregersen LH, Schueler M, Munschauer M, Mastrobuoni G, Chen W, Kempa S, Dieterich C, Landthaler M. MOV10 Is a 5\u2032 to 3\u2032 RNA helicase contributing to UPF1 mRNA target degradation by translocation along 3\u2032 UTRs. Mol Cell. 2014;54:573\u201385.","journal-title":"Mol Cell"},{"key":"382_CR19","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.cub.2005.10.048","volume":"15","author":"G Meister","year":"2005","unstructured":"Meister G, Landthaler M, Peters L, Chen PY, Urlaub H, Luhrmann R, Tuschl T. Identification of novel argonaute-associated proteins. Curr Biol. 2005;15:2149\u201355.","journal-title":"Curr Biol"},{"key":"382_CR20","doi-asserted-by":"crossref","first-page":"29373","DOI":"10.1074\/jbc.M112.354001","volume":"287","author":"C Liu","year":"2012","unstructured":"Liu C, Zhang X, Huang F, Yang B, Li J, Liu B, Luo H, Zhang P, Zhang H. APOBEC3G inhibits microRNA-mediated repression of translation by interfering with the interaction between Argonaute-2 and MOV10. J Biol Chem. 2012;287:29373\u201383.","journal-title":"J Biol Chem"},{"key":"382_CR21","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nsmb.1824","volume":"17","author":"S Messaoudi-Aubert El","year":"2010","unstructured":"El Messaoudi-Aubert S, Nicholls J, Maertens GN, Brookes S, Bernstein E, Peters G. Role for the MOV10 RNA helicase in polycomb-mediated repression of the INK4a tumor suppressor. Nat Struct Mol Biol. 2010;17:862\u20138.","journal-title":"Nat Struct Mol Biol"},{"key":"382_CR22","doi-asserted-by":"crossref","first-page":"14346","DOI":"10.1074\/jbc.M110.109314","volume":"285","author":"X Wang","year":"2010","unstructured":"Wang X, Han Y, Dang Y, Fu W, Zhou T, Ptak RG, Zheng YH. Moloney leukemia virus 10 (MOV10) protein inhibits retrovirus replication. J Biol Chem. 2010;285:14346\u201355.","journal-title":"J Biol Chem"},{"key":"382_CR23","doi-asserted-by":"crossref","first-page":"e9081","DOI":"10.1371\/journal.pone.0009081","volume":"5","author":"V Furtak","year":"2010","unstructured":"Furtak V, Mulky A, Rawlings SA, Kozhaya L, Lee K, Kewalramani VN, Unutmaz D. Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity. PLoS One. 2010;5:e9081.","journal-title":"PLoS One"},{"key":"382_CR24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","volume":"472","author":"JW Schoggins","year":"2011","unstructured":"Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM. A diverse array of gene products are effectors of the type I interferon antiviral response. Nature. 2011;472:481\u20135.","journal-title":"Nature"},{"key":"382_CR25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","volume":"1","author":"JW Schoggins","year":"2011","unstructured":"Schoggins JW, Rice CM. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol. 2011;1:519\u201325.","journal-title":"Curr Opin Virol"},{"key":"382_CR26","doi-asserted-by":"crossref","first-page":"e1002941","DOI":"10.1371\/journal.pgen.1002941","volume":"8","author":"JL Goodier","year":"2012","unstructured":"Goodier JL, Cheung LE, Kazazian HH Jr. MOV10 RNA helicase is a potent inhibitor of retrotransposition in cells. PLoS Genet. 2012;8:e1002941.","journal-title":"PLoS Genet"},{"key":"382_CR27","doi-asserted-by":"crossref","first-page":"21148","DOI":"10.1074\/jbc.M113.465856","volume":"288","author":"X Li","year":"2013","unstructured":"Li X, Zhang J, Jia R, Cheng V, Xu X, Qiao W, Guo F, Liang C, Cen S. The MOV10 helicase inhibits LINE-1 mobility. J Biol Chem. 2013;288:21148\u201360.","journal-title":"J Biol Chem"},{"key":"382_CR28","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1074\/jbc.M111.309831","volume":"287","author":"A Abudu","year":"2012","unstructured":"Abudu A, Wang X, Dang Y, Zhou T, Xiang SH, Zheng YH. Identification of molecular determinants from Moloney leukemia virus 10 homolog (MOV10) protein for virion packaging and anti-HIV-1 activity. J Biol Chem. 2012;287:1220\u20138.","journal-title":"J Biol Chem"},{"key":"382_CR29","doi-asserted-by":"crossref","first-page":"10241","DOI":"10.1128\/JVI.00585-10","volume":"84","author":"R Burdick","year":"2010","unstructured":"Burdick R, Smith JL, Chaipan C, Friew Y, Chen J, Venkatachari NJ, Delviks-Frankenberry KA, Hu WS, Pathak VK. P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages. J Virol. 2010;84:10241\u201353.","journal-title":"J Virol"},{"key":"382_CR30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1742-4690-9-112","volume":"9","author":"YH Zheng","year":"2012","unstructured":"Zheng YH, Jeang KT, Tokunaga K. Host restriction factors in retroviral infection: promises in virus-host interaction. Retrovirology. 2012;9:112.","journal-title":"Retrovirology"},{"key":"382_CR31","doi-asserted-by":"crossref","first-page":"11047","DOI":"10.1128\/JVI.02070-13","volume":"87","author":"T Izumi","year":"2013","unstructured":"Izumi T, Burdick R, Shigemi M, Plisov S, Hu WS, Pathak VK. Mov10 and APOBEC3G localization to processing bodies is not required for virion incorporation and antiviral activity. J Virol. 2013;87:11047\u201362.","journal-title":"J Virol"},{"key":"382_CR32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.virol.2015.08.026","volume":"486","author":"F Huang","year":"2015","unstructured":"Huang F, Zhang J, Zhang Y, Geng G, Liang J, Li Y, Chen J, Liu C, Zhang H. RNA helicase MOV10 functions as a co-factor of HIV-1 Rev to facilitate Rev\/RRE-dependent nuclear export of viral mRNAs. Virology. 2015;486:15\u201326.","journal-title":"Virology"},{"key":"382_CR33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.virol.2008.04.017","volume":"377","author":"JP Donahue","year":"2008","unstructured":"Donahue JP, Vetter ML, Mukhtar NA, D\u2019Aquila RT. The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation. Virology. 2008;377:49\u201353.","journal-title":"Virology"},{"key":"382_CR34","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1074\/jbc.M114.624262","volume":"290","author":"X Lu","year":"2015","unstructured":"Lu X, Zhang T, Xu Z, Liu S, Zhao B, Lan W, Wang C, Ding J, Cao C. Crystal structure of DNA cytidine deaminase ABOBEC3G catalytic deamination domain suggests a binding mode of full-length enzyme to single-stranded DNA. J Biol Chem. 2015;290:4010\u201321.","journal-title":"J Biol Chem"},{"key":"382_CR35","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3389\/fmicb.2014.00450","volume":"5","author":"Y Feng","year":"2014","unstructured":"Feng Y, Baig TT, Love RP, Chelico L. Suppression of APOBEC3-mediated restriction of HIV-1 by Vif. Front Microbiol. 2014;5:450.","journal-title":"Front Microbiol"},{"key":"382_CR36","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nsmb.3033","volume":"22","author":"T Kouno","year":"2015","unstructured":"Kouno T, Luengas EM, Shigematsu M, Shandilya SM, Zhang J, Chen L, Hara M, Schiffer CA, Harris RS, Matsuo H. Structure of the Vif-binding domain of the antiviral enzyme APOBEC3G. Nat Struct Mol Biol. 2015;22:485\u201391.","journal-title":"Nat Struct Mol Biol"},{"key":"382_CR37","doi-asserted-by":"crossref","first-page":"e95738","DOI":"10.1371\/journal.pone.0095738","volume":"9","author":"H Wang","year":"2014","unstructured":"Wang H, Liu B, Liu X, Li Z, Yu XF, Zhang W. Identification of HIV-1 Vif regions required for CBF-beta interaction and APOBEC3 suppression. PLoS One. 2014;9:e95738.","journal-title":"PLoS One"},{"key":"382_CR38","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12866-014-0290-7","volume":"14","author":"H Wang","year":"2014","unstructured":"Wang H, Lv G, Zhou X, Li Z, Liu X, Yu XF, Zhang W. Requirement of HIV-1 Vif C-terminus for Vif-CBF-beta interaction and assembly of CUL5-containing E3 ligase. BMC Microbiol. 2014;14:290.","journal-title":"BMC Microbiol"},{"key":"382_CR39","doi-asserted-by":"crossref","first-page":"29748","DOI":"10.1074\/jbc.M103093200","volume":"276","author":"T Kamura","year":"2001","unstructured":"Kamura T, Burian D, Yan Q, Schmidt SL, Lane WS, Querido E, Branton PE, Shilatifard A, Conaway RC, Conaway JW. Muf1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase. J Biol Chem. 2001;276:29748\u201353.","journal-title":"J Biol Chem"},{"key":"382_CR40","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jmb.2008.06.061","volume":"381","author":"Z He","year":"2008","unstructured":"He Z, Zhang W, Chen G, Xu R, Yu XF. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction. J Mol Biol. 2008;381:1000\u201311.","journal-title":"J Mol Biol"},{"key":"382_CR41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.virol.2004.08.006","volume":"328","author":"A Schafer","year":"2004","unstructured":"Schafer A, Bogerd HP, Cullen BR. Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor. Virology. 2004;328:163\u20138.","journal-title":"Virology"},{"key":"382_CR42","doi-asserted-by":"crossref","first-page":"35822","DOI":"10.1074\/jbc.M405761200","volume":"279","author":"ES Svarovskaia","year":"2004","unstructured":"Svarovskaia ES, Xu H, Mbisa JL, Barr R, Gorelick RJ, Ono A, Freed EO, Hu WS, Pathak VK. Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs. J Biol Chem. 2004;279:35822\u20138.","journal-title":"J Biol Chem"},{"key":"382_CR43","doi-asserted-by":"crossref","first-page":"12058","DOI":"10.1128\/JVI.78.21.12058-12061.2004","volume":"78","author":"V Zennou","year":"2004","unstructured":"Zennou V, Perez-Caballero D, Gottlinger H, Bieniasz PD. APOBEC3G incorporation into human immunodeficiency virus type 1 particles. J Virol. 2004;78:12058\u201361.","journal-title":"J Virol"},{"key":"382_CR44","doi-asserted-by":"crossref","first-page":"9314","DOI":"10.1128\/JVI.00273-11","volume":"85","author":"KL Martin","year":"2011","unstructured":"Martin KL, Johnson M, D\u2019Aquila RT. APOBEC3G complexes decrease human immunodeficiency virus type 1 production. J Virol. 2011;85:9314\u201326.","journal-title":"J Virol"},{"key":"382_CR45","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1128\/JVI.01911-09","volume":"84","author":"Q Shao","year":"2010","unstructured":"Shao Q, Wang Y, Hildreth JE, Liu B. Polyubiquitination of APOBEC3G is essential for its degradation by HIV-1 Vif. J Virol. 2010;84:4840\u20134.","journal-title":"J Virol"},{"key":"382_CR46","doi-asserted-by":"crossref","first-page":"14380","DOI":"10.1128\/JVI.02484-14","volume":"88","author":"TT Baig","year":"2014","unstructured":"Baig TT, Feng Y, Chelico L. Determinants of efficient degradation of APOBEC3 restriction factors by HIV-1 Vif. J Virol. 2014;88:14380\u201395.","journal-title":"J Virol"},{"key":"382_CR47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1101\/gr.203201","volume":"12","author":"T Doerks","year":"2002","unstructured":"Doerks T, Copley RR, Schultz J, Ponting CP, Bork P. Systematic identification of novel protein domain families associated with nuclear functions. Genome Res. 2002;12:47\u201356.","journal-title":"Genome Res"},{"key":"382_CR48","doi-asserted-by":"crossref","first-page":"13124","DOI":"10.1074\/jbc.M708728200","volume":"283","author":"Y Dang","year":"2008","unstructured":"Dang Y, Siew LM, Zheng YH. APOBEC3G is degraded by the proteasomal pathway in a Vif-dependent manner without being polyubiquitylated. J Biol Chem. 2008;283:13124\u201331.","journal-title":"J Biol Chem"},{"key":"382_CR49","doi-asserted-by":"crossref","first-page":"e1000925","DOI":"10.1371\/journal.ppat.1000925","volume":"6","author":"JR Bergeron","year":"2010","unstructured":"Bergeron JR, Huthoff H, Veselkov DA, Beavil RL, Simpson PJ, Matthews SJ, Malim MH, Sanderson MR. The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex. PLoS Pathog. 2010;6:e1000925.","journal-title":"PLoS Pathog"},{"key":"382_CR50","doi-asserted-by":"crossref","first-page":"12482","DOI":"10.1128\/JVI.05218-11","volume":"85","author":"J Wang","year":"2011","unstructured":"Wang J, Zhang W, Lv M, Zuo T, Kong W, Yu X. Identification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteins. J Virol. 2011;85:12482\u201391.","journal-title":"J Virol"},{"key":"382_CR51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature12884","volume":"505","author":"Y Guo","year":"2014","unstructured":"Guo Y, Dong L, Qiu X, Wang Y, Zhang B, Liu H, Yu Y, Zang Y, Yang M, Huang Z. Structural basis for hijacking CBF-beta and CUL5 E3 ligase complex by HIV-1 Vif. Nature. 2014;505:229\u201333.","journal-title":"Nature"},{"key":"382_CR52","doi-asserted-by":"crossref","first-page":"19539","DOI":"10.1073\/pnas.0906652106","volume":"106","author":"Y Iwatani","year":"2009","unstructured":"Iwatani Y, Chan DS, Liu L, Yoshii H, Shibata J, Yamamoto N, Levin JG, Gronenborn AM, Sugiura W. HIV-1 Vif-mediated ubiquitination\/degradation of APOBEC3G involves four critical lysine residues in its C-terminal domain. Proc Natl Acad Sci USA. 2009;106:19539\u201344.","journal-title":"Proc Natl Acad Sci USA"},{"key":"382_CR53","doi-asserted-by":"crossref","first-page":"17259","DOI":"10.1074\/jbc.M602413200","volume":"281","author":"A Mehle","year":"2006","unstructured":"Mehle A, Thomas ER, Rajendran KS, Gabuzda D. A zinc-binding region in Vif binds Cul5 and determines cullin selection. J Biol Chem. 2006;281:17259\u201365.","journal-title":"J Biol Chem"},{"key":"382_CR54","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0092-8674(00)80403-1","volume":"91","author":"D Skowyra","year":"1997","unstructured":"Skowyra D, Craig KL, Tyers M, Elledge SJ, Harper JW. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell. 1997;91:209\u201319.","journal-title":"Cell"},{"key":"382_CR55","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1128\/JVI.03824-13","volume":"88","author":"JL Fribourgh","year":"2014","unstructured":"Fribourgh JL, Nguyen HC, Wolfe LS, Dewitt DC, Zhang W, Yu XF, Rhoades E, Xiong Y. Core binding factor beta plays a critical role by facilitating the assembly of the Vif-cullin 5 E3 ubiquitin ligase. J Virol. 2014;88:3309\u201319.","journal-title":"J Virol"},{"key":"382_CR56","doi-asserted-by":"crossref","first-page":"e33495","DOI":"10.1371\/journal.pone.0033495","volume":"7","author":"X Zhou","year":"2012","unstructured":"Zhou X, Evans SL, Han X, Liu Y, Yu XF. Characterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFbeta and CRL5 E3 ubiquitin ligase components. PLoS One. 2012;7:e33495.","journal-title":"PLoS One"},{"key":"382_CR57","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.molcel.2012.12.012","volume":"49","author":"DY Kim","year":"2013","unstructured":"Kim DY, Kwon E, Hartley PD, Crosby DC, Mann S, Krogan NJ, Gross JD. CBFbeta stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression. Mol Cell. 2013;49:632\u201344.","journal-title":"Mol Cell"},{"key":"382_CR58","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1742-4690-9-53","volume":"9","author":"S Arjan-Odedra","year":"2012","unstructured":"Arjan-Odedra S, Swanson CM, Sherer NM, Wolinsky SM, Malim MH. Endogenous MOV10 inhibits the retrotransposition of endogenous retroelements but not the replication of exogenous retroviruses. Retrovirology. 2012;9:53.","journal-title":"Retrovirology"},{"key":"382_CR59","doi-asserted-by":"crossref","first-page":"11730","DOI":"10.1038\/ncomms11730","volume":"7","author":"J Li","year":"2016","unstructured":"Li J, Chen C, Ma X, Geng G, Liu B, Zhang Y, Zhang S, Zhong F, Liu C, Yin Y, et al. Long noncoding RNA NRON contributes to HIV-1 latency by specifically inducing tat protein degradation. Nat Commun. 2016;7:11730.","journal-title":"Nat Commun"},{"key":"382_CR60","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.antiviral.2015.07.009","volume":"122","author":"S Zhang","year":"2015","unstructured":"Zhang S, Zhong L, Chen B, Pan T, Zhang X, Liang L, Li Q, Zhang Z, Chen H, Zhou J, et al. Identification of an HIV-1 replication inhibitor which rescues host restriction factor APOBEC3G in Vif-APOBEC3G complex. Antiviral Res. 2015;122:20\u20137.","journal-title":"Antiviral Res"},{"key":"382_CR61","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.virol.2003.11.021","volume":"319","author":"KL Nguyen","year":"2004","unstructured":"Nguyen KL, Llano M, Akari H, Miyagi E, Poeschla EM, Strebel K, Bour S. Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression. Virology. 2004;319:163\u201375.","journal-title":"Virology"},{"key":"382_CR62","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1128\/JVI.06957-11","volume":"86","author":"T Zuo","year":"2012","unstructured":"Zuo T, Liu D, Lv W, Wang X, Wang J, Lv M, Huang W, Wu J, Zhang H, Jin H, et al. Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC. J Virol. 2012;86:5497\u2013507.","journal-title":"J Virol"},{"key":"382_CR63","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/nm1639","volume":"13","author":"J Huang","year":"2007","unstructured":"Huang J, Wang F, Argyris E, Chen K, Liang Z, Tian H, Huang W, Squires K, Verlinghieri G, Zhang H. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4\u00a0+\u00a0T lymphocytes. Nat Med. 2007;13:1241\u20137.","journal-title":"Nat Med"},{"key":"382_CR64","doi-asserted-by":"crossref","first-page":"e65040","DOI":"10.1371\/journal.pone.0065040","volume":"8","author":"X Zhou","year":"2013","unstructured":"Zhou X, Luo J, Mills L, Wu S, Pan T, Geng G, Zhang J, Luo H, Liu C, Zhang H. DDX5 facilitates HIV-1 replication as a cellular co-factor of Rev. PLoS One. 2013;8:e65040.","journal-title":"PLoS One"},{"key":"382_CR65","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1128\/JVI.69.7.4166-4172.1995","volume":"69","author":"JH Simon","year":"1995","unstructured":"Simon JH, Southerling TE, Peterson JC, Meyer BE, Malim MH. Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes. J Virol. 1995;69:4166\u201372.","journal-title":"J Virol"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-017-0382-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T13:43:02Z","timestamp":1603546982000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/s12977-017-0382-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["382"],"URL":"https:\/\/doi.org\/10.1186\/s12977-017-0382-1","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"56"}}